244 related articles for article (PubMed ID: 23749272)
21. Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior.
Lichtenstein GR; Targan SR; Dubinsky MC; Rotter JI; Barken DM; Princen F; Carroll S; Brown M; Stachelski J; Chuang E; Landers CJ; Stempak JM; Singh S; Silverberg MS
Inflamm Bowel Dis; 2011 Dec; 17(12):2488-96. PubMed ID: 21391291
[TBL] [Abstract][Full Text] [Related]
22. High Levels of Anti-GM-CSF Antibodies in Deep Infiltrating Endometriosis.
Toullec L; Batteux F; Santulli P; Chouzenoux S; Jeljeli M; Belmondo T; Hue S; Chapron C
Reprod Sci; 2020 Jan; 27(1):211-217. PubMed ID: 32046390
[TBL] [Abstract][Full Text] [Related]
23. Defective leukocyte GM-CSF receptor (CD116) expression and function in inflammatory bowel disease.
Goldstein JI; Kominsky DJ; Jacobson N; Bowers B; Regalia K; Austin GL; Yousefi M; Falta MT; Fontenot AP; Gerich ME; Golden-Mason L; Colgan SP
Gastroenterology; 2011 Jul; 141(1):208-16. PubMed ID: 21557945
[TBL] [Abstract][Full Text] [Related]
24. Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients.
Gupta N; Bostrom AG; Kirschner BS; Ferry GD; Gold BD; Cohen SA; Winter HS; Baldassano RN; Abramson O; Smith T; Heyman MB
Inflamm Bowel Dis; 2010 Apr; 16(4):638-44. PubMed ID: 19760783
[TBL] [Abstract][Full Text] [Related]
25. Disseminated Cryptococcosis Due to Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Absence of Pulmonary Alveolar Proteinosis.
Kuo CY; Wang SY; Shih HP; Tu KH; Huang WC; Ding JY; Lin CH; Yeh CF; Ho MW; Chang SC; He CY; Chen HK; Ho CH; Lee CH; Chi CY; Ku CL
J Clin Immunol; 2017 Feb; 37(2):143-152. PubMed ID: 28013480
[TBL] [Abstract][Full Text] [Related]
26. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease.
Meager A; Wadhwa M; Bird C; Dilger P; Thorpe R; Newsom-Davis J; Willcox N
Immunology; 1999 Jul; 97(3):526-32. PubMed ID: 10447777
[TBL] [Abstract][Full Text] [Related]
27. Cytokine refacing effect reduces granulocyte macrophage colony-stimulating factor susceptibility to antibody neutralization.
Heinzelman P; Carlson SJ; Cox GN
Protein Eng Des Sel; 2015 Oct; 28(10):461-6. PubMed ID: 25855658
[TBL] [Abstract][Full Text] [Related]
28. Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease--a possible target for infliximab treatment.
Agnholt J; Kelsen J; Brandsborg B; Jakobsen NO; Dahlerup JF
Eur J Gastroenterol Hepatol; 2004 Jul; 16(7):649-55. PubMed ID: 15201577
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.
Uchida K; Nakata K; Suzuki T; Luisetti M; Watanabe M; Koch DE; Stevens CA; Beck DC; Denson LA; Carey BC; Keicho N; Krischer JP; Yamada Y; Trapnell BC
Blood; 2009 Mar; 113(11):2547-56. PubMed ID: 19282464
[TBL] [Abstract][Full Text] [Related]
30. Antibody to granulocyte-macrophage colony-stimulating factor is a dominant anti-cytokine activity in human IgG preparations.
Svenson M; Hansen MB; Ross C; Diamant M; Rieneck K; Nielsen H; Bendtzen K
Blood; 1998 Mar; 91(6):2054-61. PubMed ID: 9490690
[TBL] [Abstract][Full Text] [Related]
31. Low Serum Levels of MicroRNA-19 Are Associated with a Stricturing Crohn's Disease Phenotype.
Lewis A; Mehta S; Hanna LN; Rogalski LA; Jeffery R; Nijhuis A; Kumagai T; Biancheri P; Bundy JG; Bishop CL; Feakins R; Di Sabatino A; Lee JC; Lindsay JO; Silver A
Inflamm Bowel Dis; 2015 Aug; 21(8):1926-34. PubMed ID: 25985247
[TBL] [Abstract][Full Text] [Related]
32. Cryptococcus gattii Infection as the Major Clinical Manifestation in Patients with Autoantibodies Against Granulocyte-Macrophage Colony-Stimulating Factor.
Wang SY; Lo YF; Shih HP; Ho MW; Yeh CF; Peng JJ; Ting HT; Lin KH; Huang WC; Chen YC; Chiu YH; Hsu CW; Tseng YT; Wang LS; Lei WY; Lin CY; Aoh Y; Chou CH; Wu TY; Ding JY; Lo CC; Lin YN; Tu KH; Lei WT; Kuo CY; Chi CY; Ku CL
J Clin Immunol; 2022 Nov; 42(8):1730-1741. PubMed ID: 35947322
[TBL] [Abstract][Full Text] [Related]
33. Loss of GM-CSF signalling in non-haematopoietic cells increases NSAID ileal injury.
Han X; Gilbert S; Groschwitz K; Hogan S; Jurickova I; Trapnell B; Samson C; Gully J
Gut; 2010 Aug; 59(8):1066-78. PubMed ID: 20584783
[TBL] [Abstract][Full Text] [Related]
34. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
[TBL] [Abstract][Full Text] [Related]
35. [Autoantibody against granulocyte-macrophage colony-stimulating factor and other serum markers in pulmonary alveolar proteinosis].
Xu KF; Chen Y; Guo ZJ; Zhu YJ
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):824-8. PubMed ID: 15730782
[TBL] [Abstract][Full Text] [Related]
36. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis.
Rosen LB; Rocha Pereira N; Figueiredo C; Fiske LC; Ressner RA; Hong JC; Gregg KS; Henry TL; Pak KJ; Baumgarten KL; Seoane L; Garcia-Diaz J; Olivier KN; Zelazny AM; Holland SM; Browne SK
Clin Infect Dis; 2015 Apr; 60(7):1017-25. PubMed ID: 25472947
[TBL] [Abstract][Full Text] [Related]
37. [Anti-GM-CSF autoantibodies (GM-CSF autoantibodies)].
Watanabe M
Nihon Rinsho; 2010 Jun; 68 Suppl 6():684-6. PubMed ID: 20942163
[No Abstract] [Full Text] [Related]
38. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort.
Rieder F; Hahn P; Finsterhoelzl L; Schleder S; Wolf A; Dirmeier A; Lopez R; Shen B; Rogler G; Klebl F; Lang T
Inflamm Bowel Dis; 2012 Jul; 18(7):1221-31. PubMed ID: 22147427
[TBL] [Abstract][Full Text] [Related]
39. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
Hellmich B; Ciaglo A; Schatz H; Coakley G
Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic-specific autoantibodies to glycoprotein 2 mirror disease location and behaviour in younger patients with Crohn's disease.
Bogdanos DP; Roggenbuck D; Reinhold D; Wex T; Pavlidis P; von Arnim U; Malfertheiner P; Forbes A; Conrad K; Laass MW
BMC Gastroenterol; 2012 Aug; 12():102. PubMed ID: 22866900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
